Clinical Trials List
Protocol Number1160.106
2013-11-01 - 2020-07-31
Phase II/III
Terminated2
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- CHIA -MAN CHOU Division of Pediatrics
- 張偉俊 Division of Pediatrics
- 衛皓智 Division of Pediatrics
- FANG-LIANG HUANG Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Jou Kou Wang Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
2 participants
-
Global
270 participants
